Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
3
×
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
cancer immunotherapy
clinical trials
eli lilly
immunotherapy
medicare
national
national top stories
abbvie
acute myeloid leukemia
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alx oncology
alzheimer's disease
antibiotics
autoimmune diseases
axial spondyloarthritis
bausch health
berkeley lights
biogen
biontech
biotech ipos
boehringer ingelheim
boston
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
What
companies
3
×
new
3
×
bio
hasn’t
approval
arrival
bets
biogen’s
biopharmaceutical
biotech
cancer
comes
convo
cut
date
days
deal
drug
earlier
effective
enticed
evidence
failures
industry
ipo
ipos
latest
life
littered
market
medicines
messenger
molecules
momentum
mrna
multiple
nash
news
pharmaceutical
price
Language
unset
Current search:
companies
×
deals
×
" national blog main "
×
new
×
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
